By contrast, one paper described elevated CSF BAFF levels during relapse and another one showed increased levels of CSF APRIL and BAFF in MS patients with higher levels of gray matter damage at diagnosis [44, 45]. The gene discussed is TNFSF13; the disease is myeloid sarcoma.